PI3K/MTOR Pathway Mutation
specificA change in the sequence of one or more genes that are involved in the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) signaling pathway.
Top Centers for PI3K/MTOR Pathway Mutation
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →